Company banner
NeuroPulse AI logo

NeuroPulse AI

Edge-AI non-invasive neural biosensors for real-time seizure prediction & neurological monitoring Edge-AI non-invasive neural biosensors for real-time seizure prediction & neurological monitoring.

2025
Founded
4
Team Members
$120K USD (Pre-Seed)
Seed Raised
Kandy, Sri Lanka
Location

Company Overview

Edge-AI Neurological Biosensors & Closed-Loop Clinical Diagnostics

NeuroPulse AI designs clinical-grade, non-invasive wearable neural biosensors combined with low-latency edge neural networks to predict epileptic seizures and abnormal neurological spikes up to 45 minutes before onset. By translating high-density micro-EEG signals directly on-device without requiring continuous cloud transmission, NeuroPulse empowers neurologists and patients with instantaneous proactive alerts.

Meet the Team

The passionate founders who built this company, guiding its core vision, values, and journey forward.

Dr. Keshani Alwis

Dr. Keshani Alwis

Co-Founder & CEO

PhD in Computational Neuroscience with 8+ years specializing in electrophysiological biosignal decoding and wearable sensor miniaturization.

Tharindu Jayawardena

Tharindu Jayawardena

Co-Founder & CTO

Mixed-signal ASIC engineer and firmware architect specializing in sub-milliwatt signal processing for wearable medical devices.

Dr. Arshad Rahuman

Dr. Arshad Rahuman

Co-Founder & Chief Medical Officer

Consultant Neurologist & Clinical Neurophysiologist leading multi-center clinical trials and hospital protocol compliance.

Minoli Senaratne

Minoli Senaratne

Lead AI Biosignal Engineer

Machine learning researcher specializing in temporal convolutional networks and artifact filtering for noisy physiological data.

Our Values & Our Uniqueness

The core principles guiding our mission and what sets our venture apart.

Our Values

The foundational principles and ethical standards that guide every decision we make.

Patient Dignity & Autonomy

Empowering individuals living with neurological conditions through compassionate, unobtrusive biosignal intelligence.

Our Uniqueness

The distinct capabilities, innovative approach, and competitive edge that set us apart.

What Sets NeuroPulse Apart

  • Ultra-Low-Power Edge Neural Biosensors predicting seizures up to 45 minutes prior to onset
  • Non-Invasive, Wire-Free Ergonomics engineered for comfortable 24/7 continuous ambulatory wear
  • Real-Time On-Device ML Inference eliminating the latency and privacy vulnerabilities of cloud streaming
  • Automated Emergency Geofencing & Alert Dispatch to designated clinicians and caregivers

Products & Services

Discover our portfolio of specialized products, tailored services, and core solutions built to drive success.

PulseCap Ambulatory Biosensor

Ultralight 8-channel micro-EEG headpiece with active dry electrodes and 72-hour continuous rechargeable battery life.

PulseCap Ambulatory Biosensor

NeuroCore Edge Inference Unit

Sub-milliwatt neural network accelerator chip performing real-time temporal convolutional classification at 200 Hz.

NeuroCore Edge Inference Unit

EpiGuard Clinician Portal

Cloud-synced real-time dashboard with automated anomaly triage, spike categorization, and encrypted telemedicine export.

EpiGuard Clinician Portal

Learnings in Our Journey

Key insights, field breakthroughs, and hard-earned wisdom gathered along the path of building and scaling.

Hospital Ward Ambulatory Telemetry & Motion Filtering
Clinical Research

Hospital Ward Ambulatory Telemetry & Motion Filtering

Deploying 20 PulseCap units across 45 refractory epilepsy patients showed that patient muscle movements and mastication generate significant high-frequency noise. Implementing real-time wavelet motion filtering was critical to keeping seizure prediction accuracy above 94.2%.

Dry-Contact Impedance in High Humidity Environments
Biomedical Engineering

Dry-Contact Impedance in High Humidity Environments

Tropical humidity significantly alters skin-electrode impedance over extended continuous wear. Modifying electrode surface micro-texturing preserved skin-contact impedance stability under 5 kΩ for over 48 hours without conductive gel.

Milestones

A timeline of key strategic accomplishments, technological breakthroughs, and growth benchmarks defining our journey.

Benchtop Biosignal Validation Complete

Benchtop Biosignal Validation Complete

Achieved <0.8 µV RMS noise floor on synthetic micro-EEG test benches with dry electrodes.

LeapGen HealthTech Batch 2026 Selection

LeapGen HealthTech Batch 2026 Selection

Admitted into LeapGen Acceleration program with clinical advisor board backing and prototyping grant.

Multi-Center Ethics Board Approval

Multi-Center Ethics Board Approval

Received formal ethical clearance for 100-patient extended clinical trials across three regional teaching hospitals.

Our Memories

Highlights, candid event moments, hackathons, and memorable activities from our venture journey.

First Live Clinical EEG Biosensor Calibration

First Live Clinical EEG Biosensor Calibration

Calibrating dry-electrode impedance with neurologists and volunteer subjects in the neurology research wing at Peradeniya Teaching Hospital.

LeapGen HealthTech Demo Day Showcase

LeapGen HealthTech Demo Day Showcase

Demonstrating real-time 200 Hz neural anomaly classification on stage during the annual LeapGen HealthTech Innovation Showcase.

Connect with NeuroPulse Biomedical Lab

Interested in participating in clinical trials, piloting our neural biosensors in your hospital ward, or exploring investment opportunities? Contact our team.